Using artificial intelligence to improve endoscopic ultrasound for pancreatic diseases
Official title: Artificial Intelligence in Endoscopic Ultrasound
Run by Orlando Health, Inc. · NCT06564571 · Data updated 2026-11-12
This study is testing whether an artificial intelligence system can help doctors find problems in the pancreas during ultrasound exams to improve diagnosis and reduce mistakes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 310 (estimated) |
| Sponsor | Orlando Health, Inc. Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | January 19, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | May 31, 2025 |
| Trial ID | NCT06564571 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are scheduled to undergo endoscopic ultrasound examinations.
✕Probably not a fit
Patients under 18 years of age will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the effectiveness of an artificial intelligence system in detecting pancreatic abnormalities during endoscopic ultrasound (EUS) procedures. EUS allows for detailed visualization of the pancreas and surrounding organs, aiding in the diagnosis of conditions like pancreatic cancer. The study will assess whether the AI can accurately identify abnormalities that trained endoscopists also recognize, potentially leading to a platform that enhances diagnostic accuracy and reduces the learning curve for practitioners. By correlating AI findings with expert evaluations, the research seeks to minimize human error in interpreting ultrasound images.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and efficient diagnoses of pancreatic diseases, improving patient outcomes.
How similar studies have gone: While the use of AI in medical imaging is gaining traction, this specific application in endoscopic ultrasound for pancreatic conditions is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Any patient undergoing endoscopic ultrasound examination Exclusion Criteria: * Age \< 18 years
Where it's running
-
Orlando Health
Orlando, Florida, United States Recruiting
Study contacts
- Principal investigator: Shyam Varadarajulu, MD — Orlando Health, Digestive Health Institute
- Study coordinator: Shyam Varadarajulu, MD
- Email: shyam.varadarajulu@orlandohealth.com
- Phone: 321-841-2431
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
In-depth characterisation of biliary strictures and hepato‑pancreato‑biliary focal lesions to support new diagnostic technologies
This project will collect detailed imaging and tissue data from adults with suspected bile duct, liver, pancreatic, or gallbladder lesions to help develop and test better diagnostic tools.
-
Comparing two methods for examining gastrointestinal lesions
This study is testing whether a new imaging system for examining gastrointestinal lesions works better than the standard method for people undergoing endoscopic ultrasound.
-
Using technology to improve care for pancreatic cancer patients
This study is trying to see if sharing patient data among hospitals can help improve care and outcomes for people with pancreatic cancer.
-
Registry collecting radiological data on pancreatic cancer
This study is collecting medical imaging data from patients with pancreatic cancer to see how their condition progresses and how well they respond to treatment.
-
Registry for pancreatic cysts at UCSF
This study is setting up a registry to track patients with pancreatic cysts to see how these cysts change over time and to help doctors make better treatment decisions.
-
Developing a blood test for early diagnosis of pancreatic cancer
This study is trying to develop a simple blood test to help find pancreatic cancer early and track how well treatments are working for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.